Adenovirus-mediated expression of SSAT inhibits colorectal cancer cell growth in vitro

Hui Sun1, Bin Liu, Ya-Pei Yang

  • 1Institute of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan 250012, China.

Abstract

Insights

A novel recombinant adenovirus, Ad-hTERT-SSAT, was created to express human spermidine/spermine N1-acetyltransferase (SSAT). This therapy effectively inhibits colorectal cancer cell growth by reducing polyamine levels.

Area of Science:

  • Molecular biology
  • Oncology
  • Gene therapy

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide.
  • Polyamines are essential for cell growth and proliferation, and their dysregulation is implicated in CRC development.
  • Targeting polyamine metabolism presents a potential therapeutic strategy for CRC.

Purpose of the Study:

  • To construct a recombinant adenovirus (Ad-hTERT-SSAT) expressing human spermidine/spermine N1-acetyltransferase (SSAT).
  • To evaluate the efficacy of Ad-hTERT-SSAT in inhibiting colorectal cancer cell growth in vitro.
  • To investigate the impact of SSAT expression on intracellular polyamine levels.

Main Methods:

  • Amplification and cloning of SSAT cDNA into adenoviral vectors.
  • Adenovirus packaging and amplification in HEK293 cells, monitored by GFP expression.
  • Assessment of SSAT protein levels via Western blotting and polyamine quantification using HPLC.
  • Evaluation of cell viability and growth inhibition using MTS, colony-forming, and cell count assays.

Main Results:

  • Successful construction and packaging of the Ad-hTERT-SSAT recombinant adenovirus.
  • Ad-hTERT-SSAT expression led to increased SSAT levels and significantly reduced spermidine and spermine concentrations.
  • Significant inhibition of HT-29 and LoVo colorectal cancer cell growth was observed.
  • Exogenous polyamine supplementation partially reversed the inhibitory effect of Ad-hTERT-SSAT.

Conclusions:

  • The Ad-hTERT-SSAT recombinant adenovirus effectively accelerates polyamine catabolism.
  • This approach demonstrates significant inhibition of colorectal cancer cell growth in vitro.
  • Ad-hTERT-SSAT holds potential as a therapeutic agent for colorectal cancer treatment.